Physician

Adam Widman

According to 2025 Medicare claims, Adam Widman (NPI: 1811316714) practices medical oncology in the New York-Jersey City-White Plains, NY-NJ market, with the plurality of this provider's patient population coming from New York, NY. This provider's primary affiliated billing organization is MSK MONMOUTH (NPI: 1922459163; TIN: 300937486) and primary practice location at 07748-3052.

Widman's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 53 traditional Medicare patients, billed 309 HCPCS/CPT codes, and received $18,646 in Medicare payments. The top billing code was 99215 (Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more). Part D data shows 234 prescription claims across 52 beneficiaries totaling $333,620 in drug costs, led by Letrozole (Letrozole). 2022 DME data shows 24 claims. No Open Payments records. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider has fewer than 5 years of reported Medicare Part B carrier billing data, so a reliable trend cannot be assigned. Concurrently, Part D prescription costs have risen steadily, from $18,501 to $333,620. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.